𝔖 Bobbio Scriptorium
✦   LIBER   ✦

LPS induces pulmonary intravascular macrophages producing inflammatory mediators via activating NF-κB

✍ Scribed by Zheng-Tang Chen; Sheng-Liang Li; En-Qi Cai; Wei-Ling Wu; Jing-Sheng Jin; Bo Zhu


Book ID
102301774
Publisher
John Wiley and Sons
Year
2003
Tongue
English
Weight
255 KB
Volume
89
Category
Article
ISSN
0730-2312

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Pulmonary intravascular macrophages (PIMs) are often responsible for the clearance of blood‐borne pathogens, including endotoxin, lipopolysaccharide of Gram‐negative bacteria. It is well accepted that PIMs play a pivotal role in the pathogenesis of endotoxin‐induced acute lung injury. However, the mechanisms by which PIMs are involved in the lipopolysaccharide‐induced inflammatory responses remain unclear. Through the present study the following results were found: (1) When challenged with lipopolysaccharide (10 μg/ml), PIMs underwent marked cellular enlargement, intercellular adhesion plaques became longer, and some particulates were enwrapped in the pseudopods. (2) Lipopolysaccharide could up‐regulate the expression of some inflammatory mediators in PIMs, including TNF‐α, IL‐1β, IL‐6, IL‐8, and COX‐2, and these up‐regulated expression of inflammatory mediators correlated with NF‐κB activation. (3) Dexamethasone as well as acetylsalicylic acid reduced the expression of TNF‐α in lipopolysaccharide‐challenged PIMs, and the decreased expression of TNF‐α was also consistent with decreased NF‐κB activation. Our results suggest that NF‐κB activation in PIMs followed by phagocytizing lipopolysaccharide resulted in the up‐regulation of TNF‐α, IL‐1β, IL‐6, IL‐8, and COX‐2, which could be alleviated by dexamethasone. © 2003 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Cytoplasmic bacterial lipopolysaccharide
✍ Ulrike Seitzer; Johannes Gerdes 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 473 KB

## Abstract Although many membrane components have been described to be involved in the activation of cells by bacterial lipopolysaccharide (LPS), the question remains whether LPS, once internalized by target cells, is also capable of interacting with cytoplasmic elements in such a way that activat

Roxatidine suppresses inflammatory respo
✍ Eu-Jin Cho; Hyo-Jin An; Ji-Sun Shin; Hye-Eun Choi; Jane Ko; Young-Wuk Cho; Hyung 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 638 KB

Roxatidine is a novel, specific, competitive H 2 -receptor antagonist that is used to treat gastric and duodenal ulcers, and which is known to suppress the growth of several tumors by reducing vascular endothelial growth factor (VEGF) expression. Nevertheless, it remains unclear whether roxatidine h